207 related articles for article (PubMed ID: 8191393)
1. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
2. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
3. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
4. Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia.
Långström S; Peltola V; Petäjä J; Ruuskanen O; Heikinheimo M
Acta Paediatr; 2012 Sep; 101(9):919-23. PubMed ID: 22646857
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
7. Plasma protein C levels in children with sickle cell disease.
Karayalcin G; Lanzkowsky P
Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
[TBL] [Abstract][Full Text] [Related]
8. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
9. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
11. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
12. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
13. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
Levine AB; Teppa J; McGough B; Cowchock FS
Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
[TBL] [Abstract][Full Text] [Related]
16. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
[TBL] [Abstract][Full Text] [Related]
17. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
19. Changes of hemostatic factors in patients with hemoglobinopathies.
Oner AF; Gürgey A; Okur H; Kirazli S; Gümrük F; Altay C
Turk J Pediatr; 1999; 41(3):323-7. PubMed ID: 10770092
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
